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Chapter 10
RISK CONSIDERATIONS RELATED TO ARSENIC
EXPOSURE: DRINKING WATER INGESTION VERSUS
DIETARY INTAKE OR SOIL EXPOSURE
Christopher M. Teaf1, 2, § , Douglas J. Covert 2
1

Center for Biomedical & Toxicological Research, Florida State University, 2035 E. Dirac Dr., Tallahassee,
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ABSTRACT
The February 2010 release of the Draft Toxicological Review of Inorganic Arsenic
by the U.S. Environmental Protection Agency provoked discussion of a potential
significant downward revision of the arsenic cancer slope factor (CSF), which would be
applicable to many oral exposure evaluations. Given the extreme variability in soil
cleanup guidelines that are in use throughout the United States and internationally for
arsenic, it may be appropriate to more seriously consider bifurcating the manner in which
arsenic is evaluated in environmental media. In much the same fashion by which
manganese and cadmium presently are evaluated from a risk perspective, arsenic may
lend itself to similar evaluation from a drinking water exposure standpoint separately
from a dietary or an environmental soil route of exposure. This paper examines the basis
for the current oral toxicological guidance with respect to specific exposure route and
environmental medium of exposure, and addresses possible means for alternative toxicity
guidance related to arsenic, based on differences in exposure through soil or the diet.
Keywords: arsenic, soil, organic, inorganic, drinking water, cleanup guidelines, risk,
relative bioavailability
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INTRODUCTION

Arsenic is the perennial number one entry in the CERCLA Priority List of Hazardous
Substances (ATSDR, 2007a), and is listed as a constituent of concern at more than 40%
of NPL sites (ATSDR, 2007b). Although the CERCLA list is not based solely on
toxicity, and the NPL occurrence is based primarily on exceedance of often artificially
low cleanup guidelines, the perception is such that arsenic, no matter the medium,
accessibility, or concentration, is a serious human health concern. As with most
meaningful health questions that are posed, the true answer to the question of whether
arsenic is a concern is “It depends”. It depends on the arsenic form (inorganic, organic).
It depends on the exposure medium (soil, food, air, water). It depends on the intake route
(oral, dermal, inhalation). It depends on the exposure magnitude (concentration,
duration). Any one of these factors, or more likely, a combination of them all,
determines whether arsenic can exert its ability to cause toxic effects.
In the case of arsenic toxicity, particularly from exposure to soils, health-based
screening levels and some cleanup guidelines are derived using conclusions largely based
upon long term, high concentration drinking water studies, resulting in sub part per
million protective soil targets. Human exposures to soil arsenic at concentrations far in
excess of these health-based screening levels occur frequently in all parts of the U.S. and
worldwide. However, reports conclusively connecting exposures to arsenic in soil with
adverse health effects are not readily found in the toxicological literature.

2.

NATURAL OCCURENCE

Many, if not a substantial majority of, areas in the U.S. contain soils that have
measurable levels of arsenic. Often, these detectable levels are referred to as “elevated.”
Of course, elevated is the operative word defining the discussion. Depending on the
screening level that is considered, even naturally occurring background concentrations of
arsenic in surface soil may be viewed as “elevated.” By way of example, a 2009 study by
Vosnakis, et al. evaluated more than 1,600 samples from 189 sites in seven states in the
northeastern U.S. (KY, MD, NY, OH, PA, VA, WV). The authors found that, following
data validation and site screening, the retained arsenic in soil results ranged from 1.1
mg/kg to 89 mg/kg (Vosnakis, et al., 2009; see Table 1). When compared with each
state’s soil screening level for arsenic, the reported background concentrations were from
2x to 40x greater than the respective screening levels, and the highest background level
was approximately 60x the lowest screening level.
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Table 1. Arsenic Background vs Soil Screening Levels for 7 States

Frequency
of Detection

95th Percentile
Surface Soil As
(mg/kg)

Risk Based
Screening Level
(mg/kg)

Kentucky

57 of 57

15.6

0.39

Maryland

28 of 32

10.1

0.39

New York

42 of 50

22.8

13

Ohio

94 of 143

21.7

6.8

Pennsylvania

219 of 220

23.7

12

91 of 98

13.6

0.39

314 of 316

15

8.64

State

Virginia
W Virginia

Each of these states allows for some consideration of background in their cleanup
guidance, and a few incorporate background directly into the screening levels. However,
the fact remains that large areas of soil in the U.S. exceed health-based screening levels
for arsenic.

3.

HEALTH EFFECTS

Given the intrinsic toxicity of arsenic, the very low soil screening levels theoretically
required to protect human health, and the presence in most soil of arsenic far exceeding
health-based guidelines, where are all of the reports of arsenic-related illness, disease and
death? Going briefly back to the Vosnakis, et al. (2009) study of elevated background
arsenic, we can look at selected state soil concentrations and compare those with reported
cancer incidences. As shown on Table 2, even though statewide soil arsenic
concentrations are twice or three times the national average, and up to 60-times greater
than the lowest RBSL, cancer incidence rates for bladder, liver and skin cancer are not
significantly different from national rates.
Clearly, establishing a causal link between any factor and the development of cancer
is a highly complex undertaking, but at the theoretical doses (and the associated grossly
elevated risk levels) suggested by the above soil concentrations, the logical conclusion
would be that rates broadly elevated beyond screening levels would be associated with
noticeably elevated cancer incidences. In further attempts to support that hypothesis,
Hinwood et al. (1999), in an Australian study of residential areas having soil arsenic
concentrations greater than 100 mg/kg, did not show a statistically significant increase in
relevant cancer incidences.
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Table 2. Selected State Cancer Incidence Rates (NCI, 2010)
(cases per 100,000 population per year, 2004-2008)
Bladder

Liver

Skin

Cancer

Cancer

Cancer

Incidence

Incidence

Incidence

U.S. (7.2 mg/kg; ATSDR, 2007b)

21.2

6.2

18.8

Kentucky (15.6 mg/kg)

22.6

5.1

22.3

New York (22.8 mg/kg)

23.9

7.6

15.8

Pennsylvania (23.7 mg/kg)

25.2

6.1

17.7

Location (background As)

The above observation is consistent with the opinion of multiple authors who have
proposed a sublinear or threshold basis for arsenic carcinogenicity, irrespective of
medium of exposure (Rudel, et al., 1996; ERG, 1997; ATSDR, 2007b).
Consistent with the lack of evidence supporting cancers resulting from common soil
arsenic exposures, no articles or studies were found citing systemic effects following
human exposure to arsenic in soil under normal circumstances. In a German study of the
potential transfer of arsenic from the environment to humans, it was observed that hair
and urine arsenic levels actually were lower in the study area of elevated arsenic than in
the reference area of low arsenic concentrations (Gebel, et al, 1998). Soil levels in the
former mining region ranged from 2 to 605 mg/kg, but drinking water had low arsenic,
and no occupational exposure was noted. Although a slight increase in hair and urine
levels was associated with increasing soil levels, the most significant factor contributing
to the observed levels was seafood consumption.

4.

WHY THE DISCONNECT?

So, it is clear that arsenic occurs naturally and frequently in soils at levels much
greater than health-based regulatory guidelines. There also is some evidence that cancer
incidence is not elevated in areas of elevated soil arsenic, and there is a notable lack of
evidence that elevated soil arsenic results in adverse systemic effects.
Many authors have reported on the various aspects that are involved in arsenic
occurrence in soil, exposure, toxicokinetics, and toxicity, but very little consensus has
developed at this point. Over the past several years, even the recognized certainty that
arsenic methylation in the human body is a key detoxification step has been shown to be
less than reliable (Thomas, et al., 2001; 2007; Hughes, et al., 2011; Steinmaus, et al.,
2000). Other key areas of debate include whether arsenic is indeed a linear, nonthreshold
carcinogen, or, as offered by many authors, a threshold carcinogen, or at the least a
sublinear carcinogen (ERG, 1997; Abernathy, et al., 1996; Carlson-Lynch, et al., 1994;
Lamm, et al., 2004). Separate from further refinement of the fundamental question of
carcinogenicity from drinking water exposure, this paper pursues a solution to the
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disparity between the observed drinking water toxicity and the lack of reported health
effects from exposure to elevated soil arsenic.
The list of possible explanations for the disconnect is long, and includes at least the
following:
•

arsenic form (inorganic, organic);

•

exposure medium (soil, food, air, water);

•

methylation and other toxicokinetic processes (absorption, detoxification or
activation);

•

intake route (oral, dermal, inhalation); and,

•

exposure magnitude (concentration, duration).

Any one of these factors, or more likely, a combination of them all, determines
whether arsenic can exert its potential to cause toxic effects.

5.

POSSIBLE SOLUTIONS

In order to resolve the inconsistency observed between the adverse effects from
exposure to arsenic in drinking water and the lack of actual or reported harm from
elevated soil arsenic, three of the most readily quantifiable influences were evaluated: 1)
relative bioavailability, to address intake route and exposure medium; 2) analogy to
cadmium and manganese, to address absorption and exposure medium; and, 3) inorganic
versus organic form of exposure.
5.1

Relative bioavailability adjustment

As noted earlier, a few state environmental agencies (e.g., Florida Department of
Environmental Protection) explicitly acknowledge the oft-reported reduced relative oral
bioavailability of arsenic in soil within their cleanup guidelines development process
(FDEP, 2005). The most frequently reported range for relative bioavailability adjustment
(RBA) is on the order of 20 to 60 percent (ATSDR, 2007b; Roberts, et al., 2002;
Bradham, et al., 2011; Freeman, et al., 1993; 1995), while ranges from 5 to 75 percent are
not unheard of. Thus, taking 30 percent as the midrange estimate, and 5 and 75 percent
as the low and high estimates, respectively, Table 3 presents plausible risk based
screening levels (RBSLs) for arsenic that would be calculated using procedures
consistent with development of the USEPA regional screening levels (RSLs; USEPA,
2011a).
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Table 3. Arsenic RBSLs based on estimated RBA
Reported
RBA Estimates

Default EPA RBSL
mg/kg

RBA-Based RBSL
mg/kg

Default (100%)

0.39

0.39

Upper (75%)

0.39

0.52

Mid (30%)

0.39

1.3

Lower (5%)

0.39

7.8

As shown on Table 3, the midrange RBA estimate results in a possible RBSL of 1.3
mg/kg. While this value is scientifically defensible, health-based, and it provides
considerable relief from default guidelines, it does not remotely approach naturally
occurring arsenic levels in most soils in the U.S. Thus, adjustments for RBA are
appropriate, based on a multitude of studies, but RBA adjustment is likely only a piece of
the puzzle.
5.2

Exposure medium/route adjustment

In the case of cadmium and, to a lesser extent, manganese, the route of exposure
dictates the applicable toxicological guidance that is recommended for use in risk
assessment and cleanup activities. The oral RfD for cadmium when the exposure
medium is water is 5E-4 mg/kg•day, and the oral RfD for cadmium in food is 1E-3
mg/kg•day (IRIS; USEPA, 2011b), or twice that for water. The IRIS profile for cadmium
reports that the difference in RfD values is based on observed differences in absorption
(i.e., 2.5% absorption of Cd from food or 5% from water; USEPA, 2011b). Specifically,
it states “Since the fraction of ingested Cd that is absorbed appears to vary with the
source (e.g., food vs. drinking water), it is necessary to allow for this difference in
absorption when using the toxicokinetic model to determine an RfD.” For cadmium, the
differences in toxicological guidance typically are reflected in differential media
screening levels through use of the water RfD when calculating the tapwater level and
through use of the food RfD when calculating the soil level (FDEP, 2005; USEPA,
2011a).
With respect to human absorption of arsenic, very little consensus is available, but
there does appear to be a reduced absorption rate in animal studies when comparing
insoluble, bound arsenic forms (i.e., those most often found in soil) with soluble,
unbound arsenic forms (i.e., those most often found in drinking water; ATSDR, 2007b;
NRC, 1999). Freeman et al. (1993) reported that, in rabbits, approximately 80% of the
arsenic from an ingested soil bolus (primarily smelting soil in the form of sulfides) was
eliminated (i.e., approximately 20% absorption). In contrast, 50% of a soluble oral dose
and 10% of an injected dose were eliminated (i.e., 50% and 90% absorption,
respectively). Thus, arsenic absorption from soil may range from 30-70% less than
absorption from more soluble forms. This conclusion is consistent with results from
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Roberts et al. (2002) who reported that between 60% and 80% of an ingested arsenic dose
in soil was eliminated by Cebus apella monkeys, suggesting absorption of 20% to 40%.
Although much work is needed to refine knowledge regarding human absorption
differences based on medium of exposure, the likely impact would be in the same general
magnitude as that presented for adjustments based on relative bioavailability (e.g., 1.5 to
20 fold; see Table 3).
5.3

Form of arsenic adjustment

One promising potential solution to the presence/significance conundrum may lie in
being able decisively to identify the form of arsenic, inorganic or organic, to which an
individual is exposed. Determining which form is present in the soil, and, more
importantly, identifying which form ultimately is present in the body following human
exposure, is a subject of considerable debate. However, as presented by ATSDR
(2007b), distinct chronic human oral minimal risk levels (MRLs) are available for
inorganic and organic forms of arsenic, thus providing a potential mechanism for
development of screening levels, if consensus on typical exposure forms in specific
media can be reached.
The inorganic MRL is 3E-4 mg/kg•day and that value was derived from a human
drinking water study. For the organic arsenic compounds monomethylarsonic acid
(MMA) and dimethylarsinic acid (DMA), the chronic human oral MRLs are 1E-2
mg/kg•day and 2E-2 mg/kg•day, respectively (ATSDR, 2007b), and both of these values
are based on feeding studies in mice. The MRL development process is conceptually
similar to that which is used to produce Reference Doses, including the application of
uncertainty and modifying factors. Thus, analogous to the development of USEPA
default RSLs, risk based screening levels (RBSLs) may be developed for arsenic in soil
using the MRLs for inorganic arsenic and organic arsenic compounds. As shown on
Table 4, the proposed RBSLs for organic arsenic in soil range from nearly 30 times
greater to more than 50 times greater than the RBSL for inorganic arsenic in soil.
Table 4. Arsenic RBSLs based on form-specific toxicological guidance
Chronic

Default

MRL-Based

Oral MRL

EPA RSL

RBSL

As Form

mg/kg•day

mg/kg

mg/kg

Inorganic

0.0003

0.39

22

Organic (MMA)

0.01

NA

~600

Organic (DMA)

0.02

NA

~1,200
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DISCUSSION

Significant monetary and human resources are expended on the characterization and
mitigation of arsenic in soil, based primarily on the fundamental assumption that its
potential toxicity following soil exposure is consistent with its potential toxicity
following drinking water exposure. No conclusive reports were found to support that
position, and an increasing body of evidence is available to undermine the conclusion.
While the exact mechanisms and processes that result in the disparity remain unclear, it is
time to begin refining an approach to the multiple potential solutions to the problem. As
presented in this paper, the most promising and straightforward solutions lie in
adjustments to the numerical toxicological guidance based on several factors including:
1) relative bioavailability; 2) differences in absorption between the water and soil
matrices; and/or, 3) differences in the toxicity between inorganic and organic forms of
arsenic.
Possible recommendations for future health investigations, as well as a few critical
areas for continued toxicological study include the following:

7.

•

inorganic vs organic determination whenever soil investigations take place;

•

refined toxicokinetics to conclusively identify methylation or other relevant
processes and their importance;

•

inexpensive, rapid in vitro methods for site-specific determinations of relative
bioavailability; and,

•

more conclusive determination of the mode of action for arsenic carcinogenicity.
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